Go Pro

Eden Research (EDEN) Competitors

Eden Research logo
GBX 2.99 0.00 (0.00%)
As of 07:03 AM Eastern

EDEN vs. WYN, DNK, PHC, EML, and KRPZ

Should you buy Eden Research stock or one of its competitors? MarketBeat compares Eden Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Eden Research include Wynnstay Group (WYN), Danakali (DNK), Plant Health Care (PHC), Emmerson (EML), and Kropz (KRPZ). These companies are all part of the "agricultural inputs" industry.

How does Eden Research compare to Wynnstay Group?

Eden Research (LON:EDEN) and Wynnstay Group (LON:WYN) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Wynnstay Group has a net margin of 0.51% compared to Eden Research's net margin of -65.01%. Wynnstay Group's return on equity of 2.23% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Wynnstay Group 0.51%2.23%2.08%

Wynnstay Group has higher revenue and earnings than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Wynnstay Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M6.65-£1.52M-£0.44N/A
Wynnstay Group£582.60M0.15£6.20M£11.9031.09

Eden Research has a beta of 1.813, suggesting that its share price is 81% more volatile than the broader market. Comparatively, Wynnstay Group has a beta of 0.199, suggesting that its share price is 80% less volatile than the broader market.

13.5% of Eden Research shares are owned by institutional investors. Comparatively, 5.9% of Wynnstay Group shares are owned by institutional investors. 3.2% of Eden Research shares are owned by insiders. Comparatively, 4.2% of Wynnstay Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Wynnstay Group has a consensus price target of GBX 500, indicating a potential upside of 35.14%. Given Wynnstay Group's stronger consensus rating and higher possible upside, analysts plainly believe Wynnstay Group is more favorable than Eden Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eden Research
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Wynnstay Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Wynnstay Group had 4 more articles in the media than Eden Research. MarketBeat recorded 4 mentions for Wynnstay Group and 0 mentions for Eden Research. Wynnstay Group's average media sentiment score of 1.23 beat Eden Research's score of 0.00 indicating that Wynnstay Group is being referred to more favorably in the news media.

Company Overall Sentiment
Eden Research Neutral
Wynnstay Group Positive

Summary

Wynnstay Group beats Eden Research on 13 of the 16 factors compared between the two stocks.

How does Eden Research compare to Danakali?

Danakali (LON:DNK) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Danakali has a net margin of 0.00% compared to Eden Research's net margin of -65.01%. Danakali's return on equity of 0.00% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
DanakaliN/A N/A N/A
Eden Research -65.01%-20.99%-11.29%

Danakali has higher earnings, but lower revenue than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Danakali, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danakali£67.50K0.00N/A-£1.10N/A
Eden Research£3.62M6.65-£1.52M-£0.44N/A

13.5% of Eden Research shares are owned by institutional investors. 3.2% of Eden Research shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Danakali's average media sentiment score of 0.00 equaled Eden Research'saverage media sentiment score.

Company Overall Sentiment
Danakali Neutral
Eden Research Neutral

Summary

Eden Research beats Danakali on 5 of the 8 factors compared between the two stocks.

How does Eden Research compare to Plant Health Care?

Eden Research (LON:EDEN) and Plant Health Care (LON:PHC) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

In the previous week, Eden Research's average media sentiment score of 0.00 equaled Plant Health Care'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Plant Health Care Neutral

Plant Health Care has a net margin of -35.69% compared to Eden Research's net margin of -65.01%. Eden Research's return on equity of -20.99% beat Plant Health Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Plant Health Care -35.69%-40.17%-20.92%

Eden Research has a beta of 1.813, meaning that its share price is 81% more volatile than the broader market. Comparatively, Plant Health Care has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

13.5% of Eden Research shares are owned by institutional investors. Comparatively, 24.0% of Plant Health Care shares are owned by institutional investors. 3.2% of Eden Research shares are owned by company insiders. Comparatively, 72.2% of Plant Health Care shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Eden Research has higher earnings, but lower revenue than Plant Health Care. Eden Research is trading at a lower price-to-earnings ratio than Plant Health Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M6.65-£1.52M-£0.44N/A
Plant Health Care£11.21M0.00-£4M-£0.01N/A

Summary

Eden Research and Plant Health Care tied by winning 5 of the 10 factors compared between the two stocks.

How does Eden Research compare to Emmerson?

Eden Research (LON:EDEN) and Emmerson (LON:EML) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

In the previous week, Emmerson had 1 more articles in the media than Eden Research. MarketBeat recorded 1 mentions for Emmerson and 0 mentions for Eden Research. Eden Research's average media sentiment score of 0.00 equaled Emmerson'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Emmerson Neutral

13.5% of Eden Research shares are held by institutional investors. Comparatively, 6.6% of Emmerson shares are held by institutional investors. 3.2% of Eden Research shares are held by insiders. Comparatively, 7.3% of Emmerson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Eden Research has a beta of 1.813, suggesting that its stock price is 81% more volatile than the broader market. Comparatively, Emmerson has a beta of 1.319, suggesting that its stock price is 32% more volatile than the broader market.

Emmerson has a net margin of 0.00% compared to Eden Research's net margin of -65.01%. Emmerson's return on equity of 478.72% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Emmerson N/A 478.72%-7.75%

Eden Research has higher revenue and earnings than Emmerson. Eden Research is trading at a lower price-to-earnings ratio than Emmerson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M6.65-£1.52M-£0.44N/A
EmmersonN/AN/A-£4.50M-£2.27N/A

Summary

Emmerson beats Eden Research on 6 of the 11 factors compared between the two stocks.

How does Eden Research compare to Kropz?

Eden Research (LON:EDEN) and Kropz (LON:KRPZ) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Eden Research has a beta of 1.813, meaning that its stock price is 81% more volatile than the broader market. Comparatively, Kropz has a beta of 0.405, meaning that its stock price is 60% less volatile than the broader market.

13.5% of Eden Research shares are held by institutional investors. 3.2% of Eden Research shares are held by insiders. Comparatively, 3.8% of Kropz shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Kropz has a net margin of 13.33% compared to Eden Research's net margin of -65.01%. Kropz's return on equity of 7.17% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-65.01% -20.99% -11.29%
Kropz 13.33%7.17%-7.02%

Eden Research has higher earnings, but lower revenue than Kropz. Eden Research is trading at a lower price-to-earnings ratio than Kropz, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M6.65-£1.52M-£0.44N/A
Kropz£38.52M0.56-£137.40M£0.781.67

In the previous week, Eden Research's average media sentiment score of 0.00 equaled Kropz'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Kropz Neutral

Summary

Kropz beats Eden Research on 7 of the 11 factors compared between the two stocks.

Get Eden Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDEN vs. The Competition

MetricEden ResearchAgricultural Inputs IndustryMaterials SectorLON Exchange
Market Cap£24.04M£4.48B£4.66B£2.83B
Dividend YieldN/A2.49%5.02%6.15%
P/E Ratio-6.7510.1821.42368.96
Price / Sales6.6598.846,541.0986,067.36
Price / Cash11.9016.5724.2027.87
Price / Book1.261.018.797.78
Net Income-£1.52M£62.49M£157.26M£5.89B
7 Day Performance-0.93%0.29%1.99%0.97%
1 Month Performance-10.69%-3.43%-1.64%-0.34%
1 Year Performance-20.21%7.23%46.47%70.79%

Eden Research Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDEN
Eden Research
N/AGBX 2.99
flat
N/A-20.2%£24.04M£3.62MN/A19
WYN
Wynnstay Group
4.6181 of 5 stars
GBX 348.46
+2.5%
GBX 450
+29.1%
-1.3%£80.21M£583.44M36.34944
DNK
Danakali
N/AN/AN/AN/A£73.67M£67.50KN/A5,205
PHC
Plant Health Care
N/AN/AN/AN/A£32.50M£11.21MN/A56
EML
Emmerson
N/AGBX 2.22
+0.9%
N/A+15.8%£29.67MN/AN/A1,190

Related Companies and Tools


This page (LON:EDEN) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners